Bioscript Group

Making a real difference in environmental, social and governance (ESG) matters remains a huge priority for us. This means renewing our efforts and focus on ESG measures. We remain committed to operating with integrity, supporting environmental responsibility and building a diverse and inclusive workplace where our people can thrive. Visit our website to find out more about our commitment to ESG and the measures we’re putting in place to achieve a better future. 👇 https://lnkd.in/daJEefBi #ESG #Sustainability #Governance Gabrielle Silver Jason Forward Gerdi Strydom Mark Christie

💭Did you know the secret of Bioscript Group’s deep expertise in oncology? We stay up-to-date in the rapidly evolving and complex world of oncology by partnering our brilliant academic scientists with a secret weapon: our Bioscript Data Insights (BDI) solution. BDI, our purpose-built data and insight engine, uses machine learning and artificial intelligence to generate meaningful insights that put our clients ahead of the curve, allowing our teams to build robust, narrative-led communication strategies that resonate with key stakeholders. By combining our deep clinical understanding with the power of data, we can rapidly adapt to your needs with agility and maximum value. Want to learn how our unique blend of oncology expertise and the BDI solution can elevate your communication strategies? Contact us now 👉 https://loom.ly/wzomeCg #MedComms #Oncology #MarketAccess #DataAndInsights #BioscriptDataInsights Sarah Reynolds

Patient perspectives are gaining traction in scientific publications, but a glaring issue remains: patient-authored papers are nearly impossible to identify. 🔍 This means that patient authors, who bring invaluable insights and lived experience to research, are not receiving the recognition they deserve. Why does this matter? By recognising patient authors and demonstrating that we value patient contributions, we can drive greater patient engagement, leading to more meaningful and impactful medical research that truly addresses the needs of the people it aims to help.🎯 At Bioscript Group, we empower patient authors and amplify their voices. We also recognise that meaningful patient engagement requires careful consideration of ethical guidelines, data privacy and diversity in representation. Discover our Patient Specialist Network's recommendations on ensuring effective and ethical patient authorship. 👇 #PatientEngagement #Publications #MedComms

Unlock the power of data to transform your pharma marketing and patient education strategies. 📊 Data isn't just numbers — it's a roadmap to understanding your audience and measuring the impact of your efforts. In a recent feature, James Wright, Senior Director at Bioscript Group, shares valuable insights on how pharma companies can leverage data to elevate their marketing, social media and patient education initiatives. Discover how to: ✅Uncover hidden emotions with sentiment analysis of social media content to shape impactful patient support programmes. ✅Maximise patient education by tailoring content based on patient feedback to ensure it drives better outcomes. ✅Empower healthcare professionals by leveraging data to provide targeted support and resources that enhance their roles. Don't miss this insightful article that offers a deeper dive into data-driven strategies for pharma success 👉 https://loom.ly/JfKWWno #DataAndInsights #MarketAcess #MedicalAffairs

We are very excited for the 2024 ESC Congress in London on 30th August – 2nd September! Our colleagues, Dave Andrews and Tobias Reynolds, will be in attendance. They are really looking forward to the overall topic of the congress "Personalising Cardiovascular Care" and are especially interested in exploring the sessions covering: 🧪 New lipid management approaches 🩸 Advances in antithrombotic therapies 🩺 Strategies for integrating personalised care into cardiology practice Tobias says, "As we face a growing number of patients with complex cardiovascular needs, the focus on personalised cardiovascular care is a crucial step in addressing the diverse needs of these patients. It should make for an interesting conference!" We are excited to connect and discuss the latest insights and how emerging data can help stratify patients and tailor treatments for optimal outcomes! If you’re attending and want to learn more — drop us a message to arrange a meeting in person.👇 https://loom.ly/FgfOZeE #ESCCongress #Cardiology #MedComms #MedicalAffairs

At Bioscript Group, we know that compelling communication is more than just words. It's about blending creativity with data-driven insights to craft narratives that truly resonate with their target audiences. We have developed our Bioscript Data Insights (BDI) capability to combine creative storytelling with rigorous data analysis to empower informed decision-making. 🧠 James Wright, Senior Director at BDI, explains: "Combining content creativity and information specialists with the analytical prowess of data scientists empowers our team to craft compelling narratives with data-driven insights." This unique approach ensures that our clients' messages truly stand out, driving impactful results. Whether it's launching a new treatment or educating healthcare professionals, BDI unlocks the power of data to tell stories that inform, inspire and drive action. 🙌 Discover how the Bioscript Data Insights team works across all our functions to deliver data-driven strategies and compelling narratives 👇. #MarketAccess #MedComms #DataAndInsights #BioscriptDataInsights

Regulatory writing is more than meeting deadlines and ticking boxes — it's about crafting a compelling narrative that strategically drives approvals and ultimately benefits patients. Choosing the right regulatory writing partner can make or break your drug development journey. Our latest blog post delves into the key considerations for selecting a regulatory writing partner, including: ⚖️ Balancing document and therapeutic area experience 🤝 The significance of seniority and flexibility 📝 The importance of quality and timeline adherence Don't leave your regulatory success to chance. Partner with a team that understands your needs and is committed to delivering high-quality, impactful documents. Discover how we tailor our services to your needs and deliver exceptional results: https://loom.ly/DVoDr78 #RegulatoryMedicalWriting #MedicalWriting #MedComms #HealthcareCommunications

It's National Immunisation Month, which serves as a stark reminder of the constant battle against infectious diseases. COVID-19 demonstrated the power of scientific collaboration and the importance of investing in vaccine research, but it also revealed gaps in pandemic preparedness, underscoring the urgent need for faster, more adaptable vaccine platforms. We believe that next-generation vaccine technologies, such as mRNA and viral vector platforms, are the key to safeguarding global health. Here's why: 🦠Climate change, globalisation and urbanisation are accelerating the emergence of new pathogens with pandemic potential. ⚡The development of next-generation vaccine technologies is rapid and scalable, allowing swift and effective responses to novel pathogens. 🛡️Investing in next-generation vaccine development is a proactive measure to fortify our defenses and ensure pandemic preparedness. At Bioscript Group, we're proud to partner with organisations committed to advancing vaccine research and development to protect global health. Discover more about the work we are doing in this field to drive progress and build a healthier future for all. 👇 https://lnkd.in/e-pvPhWw #NationalImmunisationMonth #InfectiousDiseases #VaccineDevelopment

As today marks World RNA Day, we celebrate the power of these molecules in transforming patients' lives. RNA molecules carry genetic instructions, help build proteins and play a critical role in gene regulation. 🧬 RNA therapy tends to target diseases that cannot be treated with other conventional drug groups and plays a crucial role in new advances against various incurable diseases. It's also expected to advance and play an integral role in the development of novel therapeutic agents for human diseases in the future. In our mission of championing innovation in rare diseases, we remain dedicated to helping you get your RNA treatments to the patients who need them most. We do this through: 🤝 Partnering with patient advocacy groups and communities  🔬 Preparing clinical trial protocols, including for gene therapies  🗃️ Generating value dossiers in ultra-rare diseases 🎓 Planning omnichannel engagement and education initiatives 📝 Developing integrated evidence plans and real-world evidence strategies  💬 Communicating key clinical and real-world evidence to clinicians and patient communities  Learn more about how we're helping close the gap in helping rare disease patients access the treatments they need. 👇 https://loom.ly/t6YQzY4 #WorldRNADay #RareDisease #RNA